{"id":"W3037517936","doi":"10.1016/j.yrtph.2020.104697","title":"Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture","year":2020,"lang":"en","type":"article","venue":"Regulatory Toxicology and Pharmacology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canadian Nuclear Laboratories","funders":"UCB Pharma; Astellas Pharma; UCB; Amgen","keywords":"Sclerostin; Medicine; Osteoporosis; Internal medicine; Adverse effect; Endocrinology; Wnt signaling pathway; Signal transduction","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003642099,0.0008246456,0.001271391,0.0003566342,0.0005443927,0.0008574434,0.000757652,0.001656697,0.006393093],"category_scores_gemma":[0.004176142,0.0003201914,0.00140754,0.0003610546,0.00061116,0.000458164,0.0002406461,0.001880014,0.0009830663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005349625,"about_ca_system_score_gemma":0.001967501,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005011406,"about_ca_topic_score_gemma":0.001591531,"domain_scores_codex":[0.9983399,0.001101197,0.00008041692,0.0001601589,0.0002332682,0.00008506634],"domain_scores_gemma":[0.997327,0.0007158725,0.0005465012,0.0002675445,0.0006855883,0.0004573636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6398273,0.03717218,0.007627991,0.004044002,0.003628832,0.0007305756,0.0004815708,0.001457108,0.06360377,0.002209072,0.0127519,0.2264658],"study_design_scores_gemma":[0.2814277,0.6322343,0.02479154,0.0005937798,0.002805153,0.001172308,0.0002080328,0.002144476,0.01446381,0.001526388,0.03857733,0.00005520633],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9297023,0.02146265,0.007944209,0.002392245,0.0009576579,0.01085054,0.004516052,0.0004169446,0.02175732],"genre_scores_gemma":[0.9739344,0.007153016,0.00357497,0.001988282,0.000657812,0.00406273,0.00239005,0.0000444727,0.006194296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006393093,"threshold_uncertainty_score":0.02138704,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05489632960896283,"score_gpt":0.3685813283115249,"score_spread":0.3136849987025621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}